Login
← Go Back
Lupin
LUPIN · Pharma > Pharmaceuticals & Drugs · Chairman: Manju D Gupta · MD: Nilesh Gupta · Listing date: Sept. 11, 2001 · Employees: 18573 · Mumbai · http://www.lupin.com
Stock Price vs Company Growth
1d
0.8%
1w
4.5%
1m
1.7%
3m
38.6%
6m
34.4%
1y
91.5%
5y
23.9%
10y
5.0%
all
18.4%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 2,152 0.8%
1,538
2,312
Company Overview
Sales
20,797 Cr
Growth: 14.2%
Profit after Tax
2,264 Cr
Growth: 18.2%
Large Cap
98,168 Cr
P/E: 43.5x
Industry P/E: 42.0x
Fundamentals
Sales (Cr) ₹ 20,797
Growth 14.2%
EBITDA 20.1%
P/S 4.7x
Dividend 0.4%
P/E 43.5x
Book Value ₹ 331
PEG Ratio 3.1x
ROE 15.9%
P/B 6.5x
Shareholding Pattern
Institutions
Life Insurance Corporation Of India
6.99 %
Hdfc Trustee Company Limited-Hdfc Flexi Cap Fund
4.28 %
Government Pension Fund Global
1.21 %
Franklin India Focused Equity Fund
1.13 %
Icici Prudential Life Insurance Company Limited
1.13 %
Promoters
Lupin Investments Pvt Ltd
45.3 %
Manju D Gupta
0.85 %
Nilesh D Gupta
0.2 %
Anuja Gupta
0.16 %
Desh Bandhu Gupta Huf
0.14 %
Others
Rakesh Jhunjhunwala
1.6 %
Nps Trust - A/C Lic Pension Fund Sch-State Govt
1.48 %
Iepf
0.15 %
Increase    Decrease    No change
Company Profile Detailed
Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India.Products and services offered by the companyGlobal FormulationsActive Pharmaceuticals Ingredients (API)BiotechSpecialty BusinessOver The Counter (OTC)Global Manufacturing & Supply ChainAwards2007: Cardinal Health Conferred Two Awards - The ‘Trade Representative Of The Year’ And The ‘Quality Supplier Award’ To Lupin Pharmaceuticals Inc.
Belongs to (39 Indices) view more
Investors (231)
lavneet
iepf
ishares....
Followers (55)
rehan
yogesh
nitin2